Top section
Top section
Upper mid-market firms eschew ‘exciting’ stories as cracks emerge in European private credit
Pharmaceuticals and energy transition also ripe sectors for M&A
Borrowers moving between the two markets create opportunities for both
More articles
More articles
More articles
-
Spanish pharma firm going all in on euro and dollar HY bonds for Biotest buy -
Healthy access to capital markets and a positive economic outlook drives Fitch's default rate prediction
-
New debt carries coupon ratchet linked to emissions performance
-
James Dervin has been appointed a managing director in Alvarez & Marsal's restructuring team
-
US methanol producer tries its luck in euro high yield debut
-
Yield hunt helps CLO issuers price more and bigger deals
Sub-sections
shared comment list
